Skip to main content
OpenTrials

Clinical trial condition

Simpson-Golabi-Behmel syndrome

Explore clinical trials studying Simpson-Golabi-Behmel syndrome. Study availability and eligibility vary by location and protocol.

12 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Simpson-Golabi-Behmel syndrome trial results

Recruiting

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

NCT06427941

Conditions
Adenocarcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Carcinoma, +14 more
Locations
  • City of Hope Phoenix Cancer Center Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Chicago Cancer Center Zion, Illinois, United States
  • Memorial Sloan Kettering Cancer Center Mskcc New York, United States
View all 47 locations
View Trial Details
Recruiting

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

NCT06795022

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
View all 20 locations
View Trial Details
Recruiting

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

NCT04928677

Conditions
Disease Attributes, Hepatoblastoma, Neoplasms, +8 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Children's Healthcare of Atlanta (Data Collection Only) Atlanta, Georgia, United States
  • Dana Farber Cancer Institute (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC

NCT06478693

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • St Vincent's Hospital Sydney, New South Wales, Australia
  • Integrated Clinical Oncology Network (ICON) Pty Ltd Woolloongabba, Queensland, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • Linear Clinical Research Murdoch, Western Australia, Australia
View Trial Details

Related conditions